Patent details

92858 Product Name: Lenvatinib, ou un de ses sels pharmaceutiquement acceptables ou un hydrate de celui-ci

Basic Information

Publication number:
92858
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019767862
Legal Status:
Active
Application number:
92858
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
09/04/2024
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
04/08/2025
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1002/001-002 Lenvima - Lenvatinib
Marketing Authorization Type:
Marketing Authorization Date:
01/06/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
23/10/2015
First Marketing Authorization date:
01/06/2015
Grant date:
23/12/2015
Activation date:
19/10/2021
Publication date:
23/12/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
19/10/2026
SPC Extension Expiration:
19/04/2027
Rejection date:
Withdrawal date:

Owner

From:
23/10/2015
 
 

Name:
Eisai R&D Management Co. Ltd.
Address:
6-10, Koishikawa, 4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/10/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WATANABE Tatsuo, c/o Eisai Co., Ltd.
Address:
Japan (JP)

2

Name:
OBAISHI Hiroshi, c/o Eisai Co., Ltd.
Address:
Japan (JP)

3

Name:
MATSUI Junji, c/o Eisai Co., Ltd.
Address:
Japan (JP)

4

Name:
SUZUKI Sachi, c/o Eisai Co., Ltd.
Address:
Japan (JP)

5

Name:
NAKAMURA Katsuji, c/o Eisai Co., Ltd.
Address:
Japan (JP)

6

Name:
TSURUOKA Akihiko, c/o Eisai Co., Ltd.
Address:
Japan (JP)

7

Name:
YOSHIBA Takako, c/o Eisai Co., Ltd.
Address:
Japan (JP)

8

Name:
MIYAZAKI Kazuki, c/o Eisai Co., Ltd.
Address:
Japan (JP)

9

Name:
MATSUI Kenji, c/o Eisai Co., Ltd.
Address:
Japan (JP)

10

Name:
FUKUDA Yoshio, c/o Eisai Co., Ltd.
Address:
Japan (JP)

11

Name:
MATSUKURA Masayuki, c/o Eisai Co., Ltd.
Address:
Japan (JP)

12

Name:
TAKAHASHI Keiko, c/o Eisai Co., Ltd.
Address:
Japan (JP)

13

Name:
SUZUKI Yasuyuki, c/o Eisai Co., Ltd.
Address:
Japan (JP)

14

Name:
MATSUSHIMA Tomohiro, c/o Eisai Co., Ltd.
Address:
Japan (JP)

15

Name:
FUNAHASHI Yasuhiro, c/o Eisai Co., Ltd.
Address:
Japan (JP)

16

Name:
HANEDA Toru, c/o Eisai Co., Ltd.
Address:
Japan (JP)

17

Name:
NOMOTO Ken-ichi, c/o Eisai Research Institute
Address:
United States (US)

18

Name:
ARIMOTO Itaru, c/o Eisai Co., Ltd.
Address:
Japan (JP)

19

Name:
YAMAMOTO Yuji, c/o Eisai Co., Ltd.
Address:
Japan (JP)

20

Name:
MIMURA Fusayo, c/o Eisai Co., Ltd.
Address:
Japan (JP)

21

Name:
YAMAGUCHI Atsumi, c/o Eisai Co., Ltd.
Address:
Japan (JP)

22

Name:
KAMATA Junichi, c/o Eisai Co., Ltd.
Address:
Japan (JP)

Publication

Bulletin

1

Bulletin Heading:
SPC3
Bulletin edition number:
2021/12
Publication date:
04/11/2021
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2024/06
Publication date:
06/05/2024
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2025/10
Publication date:
05/09/2025
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/10/2025
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
09/04/2024 Paediatric investigation plan 1
09/04/2024 Outgoing Correspondence 1
09/04/2024 Application Form 3
09/04/2024 Marketing authorization 3
09/04/2024 Summary of the product caracteristics 68
09/04/2024 General Document 2
09/04/2024 FNET_DC_FRONTPAGE 1
09/04/2024 Publication 1
04/08/2025 Outgoing Correspondence 1
07/08/2025 Publication 1
07/08/2025 Certificate 1